ABSTRACT Salix caprea L., an important medicinal plant within the family Salicaceae, holds significant value in traditional medical systems. To date, 82 compounds have been isolated and identified from this plant, including flavonoids (32 compounds, 39.02%), volatile components (19 compounds, 23.17%), and organic acids (16 compounds, 19.51%), along with salicin derivatives (8 compounds) and terpenoids (7 compounds). This review synthesizes the research progress on the phytochemical profile and pharmacological effects of Salix caprea . It analyzes the bioactivities of its various components and correlates the structural features of its flavonoids, salicin derivatives, and organic acids with their pharmacological activities, such as antioxidant and anti‐inflammatory effects mediated by acting on targets like COX‐2 and AKT1. Furthermore, it discusses the mechanisms through which these components exert their effects by modulating key molecular targets. Addressing current research limitations, such as unclear synergistic mechanisms, insufficient toxicological data, and a lack of quality control standards, this paper proposes key directions for future research. It suggests deepening investigations into molecular mechanisms and in vivo efficacy evaluations, improving safety assessment systems, and exploring modern pharmaceutical technologies like nano‐delivery systems. This review aims to provide a scientific basis for the modern development and evidence‐based medical application of this traditional medicinal plant.
Jianhua et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: